Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 247

2.

Effects of blood pressure lowering treatment in hypertension: 8. Outcome reductions vs. discontinuations because of adverse drug events - meta-analyses of randomized trials.

Thomopoulos C, Parati G, Zanchetti A.

J Hypertens. 2016 Aug;34(8):1451-63. doi: 10.1097/HJH.0000000000000972. Review.

PMID:
27228434
3.
4.
6.

Effects of blood pressure lowering on outcome incidence in hypertension. 1. Overview, meta-analyses, and meta-regression analyses of randomized trials.

Thomopoulos C, Parati G, Zanchetti A.

J Hypertens. 2014 Dec;32(12):2285-95. doi: 10.1097/HJH.0000000000000378. Review.

PMID:
25255397
8.
9.
10.

Effects of blood pressure lowering on outcome incidence in hypertension: 4. Effects of various classes of antihypertensive drugs--overview and meta-analyses.

Thomopoulos C, Parati G, Zanchetti A.

J Hypertens. 2015 Feb;33(2):195-211. doi: 10.1097/HJH.0000000000000447. Review.

PMID:
25485720
11.
12.

Blood pressure targets for hypertension in people with diabetes mellitus.

Arguedas JA, Leiva V, Wright JM.

Cochrane Database Syst Rev. 2013 Oct 30;(10):CD008277. doi: 10.1002/14651858.CD008277.pub2. Review.

PMID:
24170669
13.

Blood pressure targets for hypertension in older adults.

Garrison SR, Kolber MR, Korownyk CS, McCracken RK, Heran BS, Allan GM.

Cochrane Database Syst Rev. 2017 Aug 8;8:CD011575. doi: 10.1002/14651858.CD011575.pub2. Review.

14.

Achieved systolic blood pressure in older people: a systematic review and meta-analysis.

Moraes AAI, Baena CP, Muka T, Bano A, Buitrago-Lopez A, Zazula A, Erbano BO, Schio NA, Guedes MH, Bramer WM, Franco OH, Faria-Neto JR.

BMC Geriatr. 2017 Dec 5;17(1):279. doi: 10.1186/s12877-017-0672-4. Review.

15.

Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis.

Xie X, Atkins E, Lv J, Bennett A, Neal B, Ninomiya T, Woodward M, MacMahon S, Turnbull F, Hillis GS, Chalmers J, Mant J, Salam A, Rahimi K, Perkovic V, Rodgers A.

Lancet. 2016 Jan 30;387(10017):435-43. doi: 10.1016/S0140-6736(15)00805-3. Epub 2015 Nov 7. Review.

PMID:
26559744
16.

Randomized controlled trials of blood pressure lowering in hypertension: a critical reappraisal.

Zanchetti A, Thomopoulos C, Parati G.

Circ Res. 2015 Mar 13;116(6):1058-73. doi: 10.1161/CIRCRESAHA.116.303641. Review.

PMID:
25767290
17.

Effects of glucose-lowering on outcome incidence in diabetes mellitus and the modulating role of blood pressure and other clinical variables: overview, meta-analysis of randomized trials.

Thomopoulos C, Bazoukis G, Ilias I, Tsioufis C, Makris T.

J Hypertens. 2019 Oct;37(10):1939-1949. doi: 10.1097/HJH.0000000000002152.

PMID:
31157748
18.

Mortality implications of lower DBP with lower achieved systolic pressures in coronary artery disease: long-term mortality results from the INternational VErapamil-trandolapril STudy US cohort.

Wokhlu A, Smith SM, Gong Y, Handberg EM, Elgendy IY, Bavry AA, Cooper-DeHoff RM, Pepine CJ.

J Hypertens. 2018 Feb;36(2):419-427. doi: 10.1097/HJH.0000000000001559.

PMID:
28938338
19.

Systolic and diastolic blood pressure lowering as determinants of cardiovascular outcome.

Wang JG, Staessen JA, Franklin SS, Fagard R, Gueyffier F.

Hypertension. 2005 May;45(5):907-13. Epub 2005 Apr 18. Review.

PMID:
15837826
20.

First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.

Xue H, Lu Z, Tang WL, Pang LW, Wang GM, Wong GW, Wright JM.

Cochrane Database Syst Rev. 2015 Jan 11;1:CD008170. doi: 10.1002/14651858.CD008170.pub2. Review. Update in: Cochrane Database Syst Rev. 2018 Nov 14;11:CD008170.

PMID:
25577154

Supplemental Content

Support Center